topic-orcrp006530 News Coverage on Gilead Sciences Inc. - CTNow
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Gilead Sciences Inc.

A collection of news and information related to Gilead Sciences Inc. published by this site and its partners.

Top Gilead Sciences Inc. Articles

Displaying items 12-22
  • GLCCB to host forum on pre-exposure HIV treatment for at-risk populations

    GLCCB to host forum on pre-exposure HIV treatment for at-risk populations
    Local medical professionals will gather with members of Baltimore's gay community later this month to discuss a new medical treatment that involves HIV-negative patients taking a daily pill to avoid becoming infected. The April 28 forum, hosted by the...
  • Nasdaq plunges on tech stock sell-off

     Nasdaq plunges on tech stock sell-off
    A plunge in once-soaring technology shares sent Nasdaq into a triple-digit decline and yanked the rest of the stock market down with it. Erstwhile darlings such as Netflix Inc. and Facebook Inc., as well as biotechnology highfliers such as Intercept...
  • The $84,000 hepatitis drug [Letter]

    It was interesting to read that there is now a cure for hepatitis C in the form of new drugs that are capable of completely suppressing the virus in 90 percent of patients in 8 to 12 weeks ("Gilead Sciences' $84,000 price for hepatitis drug is...
  • Prices of new hepatitis C drugs are tough to swallow for insurers

    A pair of new drugs to treat hepatitis C offer a cure for millions of Americans afflicted with the disease — but at a potentially staggering cost to taxpayers and health plans. Until now, therapies for hepatitis C helped only about half of...
  • HIV: we can and must get to zero [Commentary]

    HIV: we can and must get to zero [Commentary]
    The havoc that HIV can wreak on a family and a community can be devastating. Over the past three decades, we have watched helplessly as friends and family members died from HIV-related illnesses. Each one lived life brimming with hope and energy, prepared...
  • From intern to T. Rowe Price portfolio manager

    From intern to T. Rowe Price portfolio manager
    A decade ago, Taymour Tamaddon was an MBA. student with a background in physics trying to convince Baltimore-based money manager T. Rowe Price to hire him as an intern. Not only did Price give him the internship and hire him later as a health care...
  • FDA approves Gilead's four-drug HIV treatment

    FDA approves Gilead's four-drug HIV treatment
    (Reuters) - U.S. health regulators on Monday approved Gilead Sciences Inc's four-drug combination pill to treat HIV, the virus that causes AIDS. The four drugs in one pill, which was formerly called the Quad and had been considered one of Gilead's more...
  • Groups moving forward to develop AIDS gel

    Groups moving forward to develop AIDS gel
    Groups working on a gel to protect women from the AIDS virus say they are moving ahead to develop the product that was hailed as "groundbreaking" after a study on its effectiveness was released in July. The developers, who met last week with the U.S....
  • FDA approves drug to prevent HIV infection

    FDA approves drug to prevent HIV infection
    The federal government has approved for the first time a drug that can prevent an HIV infection, a significant development for Baltimore where transmission rates for the virus remain high and growing. The U.S. Food and Drug Administration approved...
  • AIDS deaths worldwide drop as access to drugs improves

    AIDS deaths worldwide drop as access to drugs improves
    LOS ANGELES/GENEVA (Reuters) - Fewer people infected with HIV globally are dying as more of them get access to crucial antiretroviral drugs, particularly in sub-Saharan Africa, the United Nations AIDS program said on Wednesday. The United Nations...
  • WHO endorses use of HIV medicines for prevention

    WHO endorses use of HIV medicines for prevention
    NEW YORK (Reuters) - The World Health Organization has endorsed using HIV medicines among people who do not have the infection but are at high risk of getting it and suggested that poor and wealthy countries alike set up pilot projects to better...